Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ferric carboxymaltose versus oral ferrous sulphate for antenatal anaemia in Malawi
ACTRN12621001239853Phase 3Completed
- Sponsor
- Training and Research Unit of Excellence
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in anaemia and iron deficiency anemia (IDA) comparing Intravenous ferric carboxymaltose with Oral ferrous sulphate (2 arms). Primary endpoint: Proportion of women with anaemia. Started Nov 2021; status: completed.
02
Drugs
ferric carboxymaltoseferrous sulfate
03
Conditions
anaemiairon deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12621001239853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001239853.